These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30668408)

  • 1. Demethoxycurcumin sensitizes the response of non-small cell lung cancer to cisplatin through downregulation of TP and ERCC1-related pathways.
    Lin CY; Hung CC; Wang CCN; Lin HY; Huang SH; Sheu MJ
    Phytomedicine; 2019 Feb; 53():28-36. PubMed ID: 30668408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demethoxycurcumin-Loaded Chitosan Nanoparticle Downregulates DNA Repair Pathway to Improve Cisplatin-Induced Apoptosis in Non-Small Cell Lung Cancer.
    Chen YY; Lin YJ; Huang WT; Hung CC; Lin HY; Tu YC; Liu DM; Lan SJ; Sheu MJ
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30563166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effect of curcumin and cisplatin via down-regulation of thymidine phosphorylase and excision repair cross-complementary 1 (ERCC1).
    Tsai MS; Weng SH; Kuo YH; Chiu YF; Lin YW
    Mol Pharmacol; 2011 Jul; 80(1):136-46. PubMed ID: 21493726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-treatment with BEZ235 enhances chemosensitivity of A549/DDP cells to cisplatin via inhibition of PI3K/Akt/mTOR signaling and downregulation of ERCC1 expression.
    Xia A; Li H; Li R; Lu L; Wu X
    Oncol Rep; 2018 Oct; 40(4):2353-2362. PubMed ID: 30066933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisdemethoxycurcumin sensitizes cisplatin-resistant lung cancer cells to chemotherapy by inhibition of CA916798 and PI3K/AKT signaling.
    Wang HJ; Yang ZX; Dai XT; Chen YF; Yang HP; Zhou XD
    Apoptosis; 2017 Sep; 22(9):1157-1168. PubMed ID: 28677094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin downregulates p38 MAPK-dependent X-ray repair cross-complement group 1 (XRCC1) expression to enhance cisplatin-induced cytotoxicity in human lung cancer cells.
    Tung CL; Jian YJ; Chen JC; Wang TJ; Chen WC; Zheng HY; Chang PY; Liao KS; Lin YW
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):657-66. PubMed ID: 27026405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2.
    Ko JC; Su YJ; Lin ST; Jhan JY; Ciou SC; Cheng CM; Chiu YF; Kuo YH; Tsai MS; Lin YW
    Lung Cancer; 2010 Aug; 69(2):155-64. PubMed ID: 19962780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fucoxanthin enhances cisplatin-induced cytotoxicity via NFκB-mediated pathway and downregulates DNA repair gene expression in human hepatoma HepG2 cells.
    Liu CL; Lim YP; Hu ML
    Mar Drugs; 2013 Jan; 11(1):50-66. PubMed ID: 23299493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of mitomycin C-induced cytotoxicity by curcumin results from down-regulation of MKK1/2-ERK1/2-mediated thymidine phosphorylase expression.
    Weng SH; Tsai MS; Chiu YF; Kuo YH; Chen HJ; Lin YW
    Basic Clin Pharmacol Toxicol; 2012 Mar; 110(3):298-306. PubMed ID: 21973306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active Compounds from
    Lesmana R; Susianti ; Pediatama T; Sylviana N; Susanti Pratiwi Y; Goenawan H; Supratman U
    Pak J Biol Sci; 2021 Jan; 24(1):35-41. PubMed ID: 33683029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demethoxycurcumin, a major active curcuminoid from Curcuma longa, suppresses balloon injury induced vascular smooth muscle cell migration and neointima formation: an in vitro and in vivo study.
    Sheu MJ; Lin HY; Yang YH; Chou CJ; Chien YC; Wu TS; Wu CH
    Mol Nutr Food Res; 2013 Sep; 57(9):1586-97. PubMed ID: 23520190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA Repair Genes ERCC1 and BRCA1 Expression in Non-Small Cell Lung Cancer Chemotherapy Drug Resistance.
    Wang S; Liu F; Zhu J; Chen P; Liu H; Liu Q; Han J
    Med Sci Monit; 2016 Jun; 22():1999-2005. PubMed ID: 27289442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demethoxycurcumin increases the sensitivity of cisplatin-resistant non-small lung cancer cells to cisplatin and induces apoptosis by activating the caspase signaling pathway.
    Chen Y; Hong C; Chen X; Qin Z
    Oncol Lett; 2020 Nov; 20(5):209. PubMed ID: 32963615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-κB and MAPK/HO-1 signalling.
    Wang LH; Li Y; Yang SN; Wang FY; Hou Y; Cui W; Chen K; Cao Q; Wang S; Zhang TY; Wang ZZ; Xiao W; Yang JY; Wu CF
    Br J Cancer; 2014 Jan; 110(2):341-52. PubMed ID: 24300974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PARP inhibition selectively increases sensitivity to cisplatin in ERCC1-low non-small cell lung cancer cells.
    Cheng H; Zhang Z; Borczuk A; Powell CA; Balajee AS; Lieberman HB; Halmos B
    Carcinogenesis; 2013 Apr; 34(4):739-49. PubMed ID: 23275151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of thymidine phosphorylase expression by using an HSP90 inhibitor potentiates the cytotoxic effect of cisplatin in non-small-cell lung cancer cells.
    Weng SH; Tseng SC; Huang YC; Chen HJ; Lin YW
    Biochem Pharmacol; 2012 Jul; 84(1):126-36. PubMed ID: 22480737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin, demethoxycurcumin and bisdemethoxycurcumin differentially inhibit cancer cell invasion through the down-regulation of MMPs and uPA.
    Yodkeeree S; Chaiwangyen W; Garbisa S; Limtrakul P
    J Nutr Biochem; 2009 Feb; 20(2):87-95. PubMed ID: 18495463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combination index and glycoproteomics-based approach revealed synergistic anticancer effects of curcuminoids of turmeric against prostate cancer PC3 cells.
    Wei MM; Zhao SJ; Dong XM; Wang YJ; Fang C; Wu P; Song GQ; Gao JN; Huang ZH; Xie T; Zhou JL
    J Ethnopharmacol; 2021 Mar; 267():113467. PubMed ID: 33058923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Histoculture drug response assay guided adjuvant chemotherapy in patients with ERCC1-positive non-small cell lung cancer].
    Hirai Y; Yoshimasu T; Oura S; Tamaki T; Ota F; Nakamura R; Shimizu Y; Naito K; Ota M; Miyasaka M; Okamura Y; Nakamura Y; Yasuoka H; Kodama R
    Gan To Kagaku Ryoho; 2009 Apr; 36(4):611-4. PubMed ID: 19381033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisdemethoxycurcumin-induced S phase arrest through the inhibition of cyclin A and E and induction of apoptosis via endoplasmic reticulum stress and mitochondria-dependent pathways in human lung cancer NCI H460 cells.
    Yang ST; Huang AC; Tang NY; Liu HC; Liao CL; Ji BC; Chou YC; Yang MD; Lu HF; Chung JG
    Environ Toxicol; 2016 Dec; 31(12):1899-1908. PubMed ID: 26370218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.